Device Trial Radar · NCT07499258
Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
55
Planned (sponsor's estimate)
Start
Jul 2, 2026
Primary completion
Aug 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Axonics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 30, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.
Conditions
- Fecal Incontinence
Interventions
Axonics SNM System INS Model 5101 (R20)Device
Participants treated with the rechargeable Axonics SNM System Model 5101 also referred to as R20. Commercial devices used in this study are within their intended use as described in each geography's approved instructions for use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance/effectiveness - Improvement in Quality of Life scoring (FI)Time frame: 3 months
- Performance/effectiveness - Improvement in patient satisfaction scoring (FI)Time frame: 3 months
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Columbia University Medical Center
New York, New York · Recruiting
The Christ Hospital
Cincinnati, Ohio · Recruiting
Female Urology of Nashville Research Partnership
Nashville, Tennessee · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.